Recruiting
Phase 2

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Sponsor:

Ambrx, Inc.

Code:

NCT04829604

Conditions

HER2 Positive Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ARX788

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information